Search result for 'avastin'

Biocon Biologics receives USFDA approval for Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for treating various cancers. This approval expands the company's biosimilar oncology portfolio in...

Biocon Biologics and Sandoz have partnered to distribute two biosimilar cancer treatment products, Ogivri (Trastuzumab) and Abevmy (Bevacizumab), in Australia.